Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's After-Market Session

Author: Benzinga Insights | December 07, 2023 05:31pm

Gainers

  • Exicure (NASDAQ:XCUR) stock rose 54.5% to $0.66 during Thursday's after-market session. The market value of their outstanding shares is at $5.7 million.
  • Aligos Therapeutics (NASDAQ:ALGS) stock moved upwards by 33.84% to $0.87. The market value of their outstanding shares is at $65.1 million.
  • Tonix Pharmaceuticals (NASDAQ:TNXP) stock rose 7.86% to $0.41. The market value of their outstanding shares is at $9.7 million.
  • Reshape Lifesciences (NASDAQ:RSLS) stock rose 7.31% to $0.28. The company's market cap stands at $3.6 million.
  • Tharimmune (NASDAQ:THAR) stock moved upwards by 7.26% to $0.65. The market value of their outstanding shares is at $1.6 million.
  • Adial Pharmaceuticals (NASDAQ:ADIL) stock increased by 6.34% to $2.18. The market value of their outstanding shares is at $2.6 million.

Losers

  • Avid Bioservices (NASDAQ:CDMO) shares decreased by 22.5% to $4.1 during Thursday's after-market session. The market value of their outstanding shares is at $258.7 million. The company's, Q2 earnings came out today.
  • Processa Pharma (NASDAQ:PCSA) stock decreased by 9.53% to $0.73. The company's market cap stands at $18.0 million.
  • Solid Biosciences (NASDAQ:SLDB) stock declined by 8.69% to $5.26. The market value of their outstanding shares is at $106.1 million.
  • Modular Medical (NASDAQ:MODD) shares decreased by 7.6% to $1.46. The market value of their outstanding shares is at $30.9 million.
  • 89bio (NASDAQ:ETNB) stock fell 7.04% to $9.25. The company's market cap stands at $699.6 million.
  • Senti Biosciences (NASDAQ:SNTI) shares declined by 6.87% to $0.39. The market value of their outstanding shares is at $17.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADIL ALGS CDMO ETNB MODD PCSA RSLS SLDB SNTI THAR TNXP XCUR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist